National Research Infrastructures

« Pushing the boundaries of knowledge very often passes through the use of large research equipment, nurtured technological prowess and in the service of scientific prowess. "

NATIONAL STRATEGY FOR RESEARCH INFRASTRUCTURES 2021 EDITION

The renewal of the national strategy for research infrastructures is part of a much broader movement aimed at giving French research its rightful place in the world, in full coherence with the research programming law for the years 2021 to 2030. Infrastructures are called upon to push the boundaries of knowledge ever further, and to participate fully in the dynamics of recovery and transition driven by the France 2030 Plan, as well as by the PIA4.

23 Biogenouest core facilities are involved in 11 National Research Infrastructures.

In addition, 5 Biogenouest core facilities are associated or invited to 3 research infrastructures, without being members.

It is essential that the Biogenouest core facilities position themselves as well as possible in the national and European landscape.

The Biogenouest Steering Committee and Animation Unit, in conjunction with the Regions and the Regional Academic Delegations for Research and Innovation (DRARI), have been carrying out actions for several years on various recognition objectives:

National recognition through the IBiSA label, which remains an important objective for the Biogenouest core facilities, and through integration into the National Biology and Health Research Infrastructures (INBS) included in the roadmap;
European recognition with the ESFRI (European Strategy Forum on Research Infrastructures) roadmap.

In 2018 and 2019, Biogenouest was heavily involved in the upgrading of imaging skills and equipment in vivo of the Great West with the infrastructure coordinator France Life Imaging (FLI)The objective was to include in the FLI-2 project a Western France node which integrates the imaging core facilities in vivo Biogenouest, namely PRISM, Neurinfo and Arronax (CIMA project: Center for Applied Multimodal Imaging). At the beginning of 2020, the DGRI Health Biotechnologies steering committee gave a very favorable opinion to the enlarged FLI project, thus integrating the large western node, and granted the infrastructure funding for the period of June 2020 to June 2025.

In October 2019, following the final evaluation of the INBS of PIA 1, and positive for the infrastructure France-BioImaging (FBI), the FBI supervisory committee unanimously decided to extend its scope to the Bretagne-Loire candidate node. This node brings together the Biogenouest core facilities: MRic, H2P2, MicroPICell and APEX. It is the culmination of a work of several years which is rewarded.

In 2019, Biogenouest also supported the request for integration of the Corsaire metabolomics core facility into the national research infrastructure MetaboHUBThe roadmap for phase 2, until 2025, provides for the expansion of the infrastructure scope to three Corsair devices, namely Laberca, Ceisam and P2M2.

For the FRISBI National Research Infrastructure, which will be restricted to 3 nodes (Soleil, ESRF and Strasbourg), the "electronic" part of the MRic core facility is not directly part of the infrastructure, but it is included in the new FRISBI roadmap and as such participates in discussions and decisions.

Regarding France Bio-Imaging (FBI), the Bretagne-Loire node initially brought together MRic, MicroPICell, H2P2 and APEX. In 2021, the APEX core facility had to choose whether to belong to a single national infrastructure and decided to keep Neuratris. Despite this, the current dynamic between the 4 core facilities will be maintained. The proof of concept project for multi-modalities without marking to demonstrate the complementarity between the core facilities was launched with the recruitment of an engineer funded via Biogenouest.

At the start of 2024, 23 Biogenouest core facilities are involved in 11 different national Research Infrastructures.

The Animation Unit continues to promote with the managers of the Biogenouest core facilities their rapprochement and/or integration into the national Research Infrastructures.